Reviews 1,393 4.6 HSA/FSA Weight Loss A next-generation compounded GLP-1/GIP injection with tirzepatide, combining dual pathways for appetite regulation and metabolic improvement, designed to support significant progress in weight care and health goals
A few more serious side effects, like pancreatitis and thyroid C-cell tumors, did appear in some trials, but more testing is needed
Kidney and cardiovascular outcomes SURPASS-4 kidney composite HR 0.58, slower eGFR decline (-1.4 vs -3.6 mL/min/1.73m2/yr), UACR -6.8% vs +36.9%
Compounded tirzepatide from telehealth platforms in 2026 ranges from $199 to $549 per month depending on dose and provider
For weight loss to be sustained, you need continuous receptor activationsomething 2-week intervals struggle to provide